scholarly journals Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore

2016 ◽  
Vol 57 (01) ◽  
pp. 8-12 ◽  
Author(s):  
ZM Wang ◽  
JH Law ◽  
NK King ◽  
DK Rajeswaran ◽  
S Soh ◽  
...  
Keyword(s):  
Brain Injury ◽  
Acquired Brain Injury ◽  
Intrathecal Baclofen ◽  
Tertiary Institution ◽  
Intrathecal Baclofen Therapy

scholarly journals Outcomes of intrathecal baclofen therapy in patients with cerebral palsy and acquired brain injury

Medicine ◽  
2017 ◽  
Vol 96 (34) ◽  
pp. e7472 ◽  
Author(s):  
Young Kwon Yoon ◽  
Kil Chan Lee ◽  
Han Eol Cho ◽  
Minji Chae ◽  
Jin Woo Chang ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Brain Injury ◽  
Acquired Brain Injury ◽  
Intrathecal Baclofen ◽  
Intrathecal Baclofen Therapy

Timing of intrathecal baclofen therapy in persons with acquired brain injury: Influence on outcome

Brain Injury ◽  
2013 ◽  
Vol 27 (13-14) ◽  
pp. 1671-1675 ◽  
Author(s):  
Federico Posteraro ◽  
Benedetta Calandriello ◽  
Rosita Galli ◽  
Fiammetta Logi ◽  
Laura Iardella ◽  
...  
Keyword(s):  
Brain Injury ◽  
Acquired Brain Injury ◽  
Intrathecal Baclofen ◽  
Intrathecal Baclofen Therapy

Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report

1997 ◽  
Vol 87 (3) ◽  
pp. 415-419 ◽  
Author(s):  
Jay M. Meythaler ◽  
Anne McCary ◽  
Mark N. Hadley
Keyword(s):  
Brain Injury ◽  
Infusion Pump ◽  
Acquired Brain Injury ◽  
Intrathecal Baclofen ◽  
Intrathecal Administration ◽  
Content Type ◽  
Severe Spasticity ◽  
Prospective Assessment ◽  
Intrathecal Infusion ◽  
Fine Print

✓ Twelve consecutive patients with severe spasticity and hypertonia following acquired brain injury were treated with continuous intrathecal infusion of baclofen via an implanted, programmable infusion pump—catheter system for a minimum of 3 months. In every case intrathecal baclofen therapy resulted in a statistically significant reduction in upper- and lower-extremity tone, spasm frequency, and reflexes, contributing to improved functional abilities. There were no untoward side effects or complications associated with treatment. This preliminary assessment indicates that intrathecal administration of baclofen is effective in treating the disabling spasticity caused by acquired brain injury in selected patients.

Sign in / Sign up

Export Citation Format

Share Document